Study in Men With Prostate Cancer to Assess the Safety, Pharmacokinetics and Testosterone-Lowering Efficacy of TAK-448

NCT01132404 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
9
Enrollment
INDUSTRY
Sponsor class

Stopped Developing new formulation of study drug. New study to open next year under a new protocol.

Conditions

Interventions

Sponsor

Millennium Pharmaceuticals, Inc.